Pain Management News

An intervention failed to increase patient activation, but it helped to improve depression, patient portal management and other health measures among patients with chronic pain on long-term opioids, according to a randomized trial.

The overall use of several complementary health approaches, and their use for pain management specifically, rose substantially over the last couple of decades, researchers found.

The FDA has granted breakthrough therapy designation to PF614-MPAR, a “next-generation opioid” designed to limit oral overdose potential, according to a press release from its manufacturer.

Gabapentinoid use has continued to increase in the last several years despite a “dearth of evidence” that supports the drug’s use, according to researchers.

A 55-year-old man new to the area presents to the ED complaining of excruciating left flank pain that radiates into his scrotum. He noted blood in the urine this morning and became worried enough to seek emergency care.

The FDA has approved an abbreviated new drug application from ANI Pharmaceuticals for indomethacin oral suspension, a generic version of Indocin oral suspension, according to a press release from the manufacturer.

The FDA on Friday authorized a drug importation for Florida’s Agency for Health Care Administration that will enable the state to import prescription drugs from Canada, according to an agency news release.

The state of pain management in rheumatology has always been in flux.

The FDA has approved AvertD, the first DNA test to identify an elevated risk for developing opioid use disorder, according to a press release.

WHO recently released recommendations on managing chronic low back pain in primary care — the organization’s first ever guidelines on the subject.